Scientists investigating the mechanics of the early stages of lung cancer have identified a new potential treatment, which could also aid early detection of the disease. Levels of a key protein -- called TLR2 -- in tumors was found to predict a patient's survival after being diagnosed with lung cancer, a study shows. A drug compound that activates TLR2 was tested in mice and was found to reduce tumor growth in the early stages of the disease.